Table 2 Clinical and laboratory indicators of patients with PMN.
Number | Variable |
|---|---|
X1 | Gender |
X2 | Age |
X3 | Hypertension |
X4 | Systolic blood pressure |
X5 | Diastolic blood pressure |
X6 | RAS Inhibitor |
X7 | Diabetes mellitus |
X8 | Serum albumin |
X9 | Proteinuria |
X10 | Serum creatinine |
X11 | Urea nitrogen |
X12 | Serum glucose |
X13 | Uric acid |
X14 | Estimated glomerular filtration rate |
X15 | Triglyceride |
X16 | Total cholesterol |
X17 | Low-density lipoprotein cholesterol |
X18 | Hemoglobin |
X19 | C-reactive protein |
X20 | Erythrocyte sedimentation rate |
X21 | IgG epitope spreading |
X22 | IgG4 epitope spreading |
X23 | PLA2R-IgG (ELISA) |
X24 | PLA2R-IgG (TRFIA) |
X25 | PLA2R-IgG4(TRFIA) |
X26 | PLA2R-CysR-IgG(TRFIA) |
X27 | PLA2R-CysR-IgG4(TRFIA) |
X28 | PLA2R-CTLD1-IgG(TRFIA) |
X29 | PLA2R-CTLD1-IgG4(TRFIA) |
X30 | PLA2R-CTLD678-IgG(TRFIA) |
X31 | PLA2R-CTLD678-IgG4(TRFIA) |
